Cellular Senescence Drives Diabetic Atherosclerosis: Aging Mechanisms And Integrative Therapeutic Implications
Our bodies are complex, and as we age, or when conditions like diabetes are present, our cells can undergo changes that impact our health. One such change is called cellular senescence. Imagine a cell that decides to retire—it stops dividing, but it doesn’t just sit quietly. Instead, these “retired” cells become quite active, releasing a mix of inflammatory signals and other harmful substances. This release is known as the Senescence-Associated Secretory Phenotype, or SASP.
This SASP is a big deal because it can trigger a cascade of problems in the body, including ongoing inflammation, a type of cellular damage called oxidative stress, and a reduction in a vital molecule called nitric oxide, which helps keep our blood vessels healthy. The combination of these factors contributes significantly to the damage seen in the heart and blood vessels, particularly in individuals who are aging or have diabetes.
Essentially, these senescent cells appear to be a crucial connection, explaining why aging and diabetes often go hand-in-hand with an increased risk of cardiovascular diseases like atherosclerosis, where plaque builds up in the arteries. Understanding this link opens up exciting possibilities for new treatments that could target these senescent cells, potentially slowing down or even preventing the progression of these debilitating conditions.
Source: link to paper